Advertisement

Topics

Alcon Company Profile

12:47 EST 13th December 2018 | BioPortfolio

The Alcon group's U.S. headquarters in Fort Worth, Texas, (about 30 miles west of Dallas) is our largest location with over 2,500 employees. We continue to build our team for the future across the United States and worldwide.
We seek dedicated individuals who share our vision of diversified specialization in the field of ophthalmology -- people who are committed to their careers as a means of securing a successful future for themselves while adding value to the world in which they live.

Location

6201 S. Freeway
Fort Worth
76134-2099
United States of America

Contact

Phone: 41+41-785-8888
Email: webmaster@alconlabs.com


News Articles [91 Associated News Articles listed on BioPortfolio]

Novartis: Problem-Sparte Alcon vor Mega-IPO?

Die Novartis-Division Alcon gilt als das große Problemkind im Konzernverbund. Zwar konnte die Sparte zuletzt wieder auf den Wachstumspfad zurückkehren. Doch nach der Übernahme von Alcon im Jahr 201...

Alcon spin-off prompts Novartis downgrade by Moody’s

Selling off Alcon concentrates business in riskier areas

Alcon expands its global support of eye care professionals through Alcon Experience Academy

Alcon, the global leader in eye care and a division of Novartis, is expanding its extensive, global support of eye care professionals through the unveiling of the Alcon Experience Academy.

Novartis spins off Alcon as CEO focuses drug search

Novartis has announced a plan to spinoff Alcon – its eye care division – into a separately-traded standalone company. Novartis has announced a plan to spinoff Alcon – its eye care division – i...

Novartis trennt sich von Augensparte Alcon: Alcon soll als eigenständiges Unternehmen an die Börse gehen. ...

Alcon soll als eigenständiges Unternehmen an die Börse gehen. Damit die neue Firma starten kann, benötigt Novartis aber noch grünes Licht von seinen Aktionären.Novartis drückt bei der Neuausrich...

Alcon to build digital platform to improve cataract surgery

Novartis’ ophthalmology division Alcon has announced plans to build a digital platform to streamline, simplify and improve cataract surgery for surgeons and patients. Alcon will use its SMART digit...

Novartis announces plan to spin off Alcon

Eye-care unit Alcon will be spun off into a standalone business by its parent company Novartis as the latter intends to focus -More- 

Alcon to Develop SMART Suite Digital Health Platform for Cataract Surgery

Alcon, the global leader in eye care and a division of Novartis, today announced plans to develop the SMART Suite by Alcon, an innovative, digital platform that is designed to streamline, simplify and...

Drugs and Medications [97 Associated Drugs and Medications listed on BioPortfolio]

Bion tears [Alcon Laboratories, Inc.]

BION® TEARSLUBRICANT EYE DROPS

Systane [Alcon Laboratories, Inc.]

SYSTANE® BALANCE Lubricant Eye Drops

Systane [Alcon Research Ltd]

SystaneLubricant Eye Drops

Systane [Alcon Research Ltd]

Systane ULTRALubricant Eye Drops

Naphcon a®eye drops [ALCON LABORATORIES, INC.]

Naphcon A®Eye Drops

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens.

To simplify the medical treatment of glaucoma for patients on multiple drops by introducing brinzolamide/brimonidine tartrate fixed combination (BBFC) ophthalmic suspension 1%/0.2% (SIMBRINZA; Alcon L...

Supraciliary Microstent in Refractory Open-Angle Glaucoma: Two-Year Outcomes from the DUETTE Trial.

The aim of the study was to report longer term (24-month) outcomes for primary open-angle glaucoma (POAG) patients refractory to medical therapy implanted with a supraciliary microstent (CyPass Micro-...

Clinical Trials [31 Associated Clinical Trials listed on BioPortfolio]

The Incidence of Glistenings in the 2017 Intraocular Lenses Made by Alcon and Abbott Medical Optics

The purpose of this study is to seek academic/non-industry research funding support to independently investigate the incidence and density of lens glistenings in cataract patients who are ...

Comparison of Functional Vision Provided by AMO Tecnis Z9000 and Alcon SA60AT Acrysof

This study is to compare intraindividually the functional vision provided by two different posterior chamber intraocular lenses: AMO Tecnis Z9000 and Alcon SA60AT Acrysoft. To see if the a...

Evaluation of Disinfecting Solutions and Protein Remover With a Silicone Hydrogel Lens

The purpose of this study is to determine if reduced lens deposits and increased comfort can be achieved by using Multipurpose disinfecting solutions (MPDS) in a no-rub format but in conju...

Prospective Comparative Study of Refractive Outcome of STAAR and Alcon Toric Intraocular Lenses

Several methods have been developed to address and reduce preexisting astigmatism. The refractive results associated with the use of toric IOLs are likely to be more predictable. Other adv...

Tobramycin-Dexamethasone Versus Tobramycin-Dexamethasone Plus Ketorolac After Phacoemulsification Surgery

This randomized controlled trial compares two regimens of topical therapy: - tobramycin 0.3% - dexamethasone 0.1% (TobraDex®, Alcon), one drop four times/day - combination of tobr...

Companies [9 Associated Companies listed on BioPortfolio]

Alcon, Inc.

Alcon, Inc. is the world’s leading eye care company, with sales of approximately $6.5 billion in 2009. Alcon, which has been dedicated to the ophthalmic industry for 65 years...

Alcon

The Alcon group's U.S. headquarters in Fort Worth, Texas, (about 30 miles west of Dallas) is our largest location with over 2,500 employees. We continue to build our team for the future across the Uni...

StrikeForce Communications LLC

StrikeForce is an award-winning full service agency with a stack of consumer and professional accounts. Clients include both industry giants and specialty companies such as Abbott...

LaVoie Group

LaVoie Group provides senior-level strategic counsel and tactical implementation of strategic communications programs designed to properly position, create visibility and drive value for each client. ...

PanOptica, Inc.

PanOptica, Inc. is a private, venture-backed biopharmaceutical company focused on licensing and developing a portfolio of exciting and innovative therapeutics for major ophthalmic diseases. Since its ...

More Information about "Alcon" on BioPortfolio

We have published hundreds of Alcon news stories on BioPortfolio along with dozens of Alcon Clinical Trials and PubMed Articles about Alcon for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alcon Companies in our database. You can also find out about relevant Alcon Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record